in-person Meeting Information
Our meetings are free and open to all. No registration required, just show up!
We meet every 3rd Saturday of the month (except December) starting at 10:00 AM PT.
Video of the meetings are available on our IPCSG YouTube channel the week following the meetings.
https://www.youtube.com/@ProstateCancerSupport
As always, spouses/partners and caregivers are welcome and encouraged to attend!
Sanford Burnham Prebys Medical Discovery Institute (Building 12)
10905 Rd to the Cure, San Diego, CA 92121
(Press the button below, enter your location then press enter)
August 16, 2025 10AM PT
Traci Roberts, MS, RD - Nutrition and Cancer
We are excited to welcome Traci Roberts, MS, RD, a registered dietitian and expert in medical nutrition therapy, as our upcoming presenter. Traci brings a wealth of experience from her work at UC San Diego Health’s Moores Cancer Center, where she supports patients with chronic illnesses such as cancer through individualized nutrition counseling. Her patient-centered approach and deep understanding of the link between diet and disease make her an invaluable voice in the field of integrative cancer care.
With a strong background in nutrition science and biochemistry, Traci also plays a key role in research exploring the effects of cancer-related weight and muscle loss on treatment outcomes. Attendees can look forward to practical insights and evidence-based strategies to enhance health and quality of life through nutrition.
July 19, 2025 10:00 AM PT
IPCSG Roundtable
Come hear real stories from real men who have faced prostate cancer head-on.
Richard Opper, John Love, and Marc McGuire, will share their personal journeys and insights on a wide range of topics such as Active Surveillance, Focal Therapy, Surgery, Radiation, Recurrence, and more.
Whether you're newly diagnosed, in treatment, or supporting a loved one, this is a unique opportunity to hear firsthand experiences—what worked, what was challenging, and what they wish they’d known sooner.
After the panel, stick around for a combined Q&A session where you can ask anything that’s on your mind. No doctors, no pressure—just honest, heartfelt answers from men who have truly “been there, done that.”
Don’t miss this chance to connect, learn, and feel supported. We look forward to seeing you there!
June 21, 2025 10AM PT
Dr. Rajiv Chopra - Founder of Profound Medical and Inventor of the TULSA Procedure
Dr. Chopra will present an in-depth overview of the TULSA Procedure, including the innovative technology behind it, its key differentiators compared to other treatments for localized prostate conditions, and its clinical benefits.
He will also discuss the development history of TULSA and share his insights on the future direction of this radiation-free and FDA cleared treatment.
For more information about TULSA CLICK HERE
MAY 17, 2025 10:00 AM PT
Dr. Aditya Bagrodia - Focal therapy for prostate cancer: Who, when, and how?
Dr. Aditya Bagrodia Professor of Urology, Genitourinary Oncology Disease Team Leader, UC San Diego Health, is a board-certified urologist specializing in the detection, treatment, and prevention of genitourinary cancers.
Dr. Bagrodia brings extensive expertise in treating a wide range of urologic cancers, including adrenal, kidney, upper urinary tract, bladder, prostate, penile, and testicular cancers. He is highly skilled in both surgical and nonsurgical treatments, with a special focus on minimally invasive techniques that improve recovery time and overall patient outcomes.
Dr. Bagrodia will discuss the latest advancements in urologic cancer treatment, providing valuable insights into the newest surgical approaches, medications, and personalized therapy options. His patient-centered approach ensures that individuals can navigate their treatment options with a focus on both survival and quality of life.
MARCH 15, 2025 10:00 AM PT
Dr. Richard Lam MD,
Prostate Oncology Specialists – 2025 Update on Prostate Cancer
Join us for an insightful and engaging update from Dr. Richard Lam, a double board-certified internist and oncologist who has dedicated his career to the specialized treatment of prostate cancer at Prostate Oncology Specialists since 2001.
Renowned for his expertise, Dr. Lam will delve into the latest advancements in prostate cancer, including cutting-edge treatments, emerging clinical trials, and groundbreaking research that are shaping the future of care. His ability to present complex medical information in a clear, accessible, and engaging manner makes his talks a must-attend for anyone seeking the most up-to-date knowledge in the field.
Beyond his depth of knowledge, Dr. Lam’s presentations are known for their wit and humor, ensuring an informative and enjoyable experience. Don’t miss this opportunity to hear from one of the leading voices in prostate oncology!
February 22, 2025 10:00 AM PT
Due to the wildfires in Los Angeles, the Genesis Invitational golf tournament has been moved to Torrey Pines, Feb. 10th through the 16th. Due to the anticipated heavy traffic and lack of parking, the February 15th IPCSG meeting has been moved to the next Saturday, February 22nd.
First Presentation
Stephen L Pendergast - Prostate Cancer Clinical Trial overview
Clinical trials for prospective prostate cancer treatments follow a structured process that involves multiple stakeholders, including pharmaceutical companies, academic laboratories, healthcare providers, government regulators, and patients. Each plays a critical role in the formulation, execution, and oversight of these trials.
Stephens presentation will give an overview of the process from the beginning till trial completion.
Stephens Slides
Prostate Cancer Clinical Trials White Paper
Second Presentation
Teresa Gallagher, Ph.D., MPH
Sparrow Search - Connecting patients with clinical trials
There are over 1,000 prostate cancer clinical trials looking for patients at more than 5,000 clinics throughout the U.S. Sparrow Search helps you to find the right studies and connect with them.
A live demonstration will be done to show how Sparrow Search helps you find the trials that are out there, and which ones you might be eligible to join.
Watch both presentations on YouTube
January 18, 2025 10am pt
2025 Updates on Radiation Oncology
Arno J. Mundt, MD, FACRO, FASTRO
Radiation Oncologist and Professor and Chair of Radiation Medicine and Applied Sciences
Brent Rose, MD
Radiation Oncologist and Assoc. Professor and Division Director of Radiation Medicine and Applied Sciences
Iain Macewan, MD
Radiation Oncologist and Assoc. Professor and Division Director of Radiation Medicine and Applied Sciences.
The speakers will give an introductory overview of radiation oncology as it relates to prostate cancer, including both photon and proton radiation.
october 19, 2024 10AM PT
TREATMENTS FOR ADVANCED PROSTATE CANCER
Rana R. McKay, MD, is a board-certified medical oncologist who specializes in treating people with urogenital cancers, including bladder, kidney, prostate and testicular cancer.
Dr. McKay leads a multi-disciplinary prostate cancer clinic focused on delivering advanced cancer care through a coordinated team approach.
Dr. McKay will be highlighting recent FDA approved treatments for advanced prostate cancer. Additionally, she will discuss current novel treatments that are in development and clinical trials of the next generation treatments for prostate cancer.
september 21, 2024 10AM PT
THE ROLE OF PROTON THERAPY IN THE MANAGEMENT OF SOLID TUMORS: CURRENT STATE AND FUTURE DIRECTIONS
Dr. Ramesh Rengan is currently the Peter Wootton Chair and Professor in the Department of Radiation Oncology at the University of Washington School of Medicine and the Senior Vice President and Director in Radiation Oncology Division at the Fred Hutchinson Cancer Center. He also holds a joint appointment as faculty of the Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center.
His clinical interests include thoracic malignancies, melanomas (including ocular melanoma), renal cell carcinoma, and prostate cancer. Additionally, he has clinical expertise in the use of proton beam therapy in the management of localized and locally advanced solid tumors. His research interests include approaches to improve the therapeutic ratio in solid tumors to ionizing photon or proton radiation, pre-clinical and clinical strategies to utilize radiation to trigger an anti-tumor immune response in patients with advanced solid malignancies.
He also has an interest in healthcare disparities and expanded access to radiation treatment in low-resource environments and Photon- and Proton based radiation regimens to trigger an immune response to augment immunotherapeutic platforms in solid malignancies including NSCLC, melanoma, lymphoma, and renal cell carcinoma.
August 17, 2024 10AM PT
Future of Precision Medicine – Prostate Cancer
Denise Guilbault from Telix pharmaceuticals will give a presentation on their new Lutetium based therapy and their current diagnostic tools.
Telix, based in Australia, is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals.
Denise is a Medical Science Liaison with a decade of successful experience in supporting drug development from pre-launch to post marketing research in the solid tumor space, focusing on prostate cancer, breast cancer, and melanoma, . Previously, she worked for two decades in nuclear medicine imaging and patient care in the imaging suite. She now works directly with researchers in enrolling patients into Telix-sponsored trials and in supporting investigator-initiated studies.
For more information, visit their website: https://telixpharma.com/
July 20, 2024 10am pt
ROUNDTABLE
Three members of the IPCSG group will share stories about their journey with Prostate Cancer.
- Bill Manning
- Mike McCarey
- Herschel Kagan
This is your chance to get all your questions answered by men who have
"been there, done that".
March 16, 2024 10AM PT
Dr. Kipper - PET/CT imaging technology
Dr. Kipper is one of the nation’s foremost experts in PET/CT imaging technology for the diagnosis of cancer and brain disorders. He is the author of several medical textbooks and numerous professional journal articles on imaging techniques for the evaluation of cancer and other disease processes.
February 17, 2024 10AM PT
IPCSG Roundtable
Three members of the IPCSG group will share stories about their journey with Prostate Cancer.
- Dennis Hickey
- Don Wang
- North County Cancer Fitness - Karla Going President
This is your chance to get all your questions answered by men who have
"been there, done that".
January 20, 2024 10AM PT
Dr. A. J. Mundt MD,
UCSD Radiation Oncology
Updates on Radiation Oncology
Arno J. Mundt, MD, FACRO, FASTRO
- Radiation Oncologist and Professor and Chair of Radiation Medicine and Applied Sciences
- Dr. Mundt will be introducing the other speakers and giving an introductory overview of radiation oncology as it relates to prostate cancer.
Other speakers to be announced.
December 2023
No Meeting in December
The IPCSG team wishes you and your loved ones a very Merry Christmas filled with love, laughter, and good health.
We are looking forward to a happy and healthy 2024 for all!
November 18, 2023 10:00AM PT
Sam Denmeade, M.D. - bipolar androgen therapy (BAT)
Dr. Denmeade is the R. Dale Hughes Professor of Oncology and Urology at the Johns Hopkins University School of Medicine and Director of the Genitourinary Oncology Division for the Johns Hopkins Kimmel Cancer Center. His areas of clinical expertise include bladder cancer, kidney cancer, prostate cancer and testicular cancer.
He will be discussing Bipolar Androgen Therapy (BAT), a new endocrinologic treatment for castration-resistant prostate cancer (CRPC). BAT is a treatment in which testosterone levels are oscillated between low and high levels in order to prevent the adaptation of prostate cancer cells to a low-androgen environment.
Dr. Rana McKay
October 21, 2023 10:00 AM PT
“Novel Therapeutic Strategies for Patients with Advanced Prostate Cancer”
Rana R. McKay, MD, is a board-certified medical oncologist who specializes in treating people with urogenital cancers, including bladder, kidney, prostate and testicular cancer.
Dr. McKay leads a multi-disciplinary prostate cancer clinic focused on delivering advanced cancer care through a coordinated team approach.
Dr. McKay will be highlighting recent FDA approved treatments for advanced prostate cancer. Additionally, she will discuss current novel treatments that are in development and clinical trials of the next generation treatments for prostate cancer.